Zhangjiang Group

Zhangjiang Group is a state-backed investment firm based in Shanghai, China, specializing in technology and innovation investments. The firm focuses on sectors such as biotechnology, healthcare, semiconductors, information technology, robotics, pharmaceuticals, medical devices, software, artificial intelligence, consumer electronics, automotive, renewable energy, environmental services, and logistics. It invests across various stages, including early stage, growth, and late stage, primarily within China.

The firm's investment strategy emphasizes fostering innovation and supporting the development of emerging industries. Zhangjiang Group has been instrumental in the growth of the Zhangjiang Hi-Tech Park, a prominent technology hub in Shanghai, which hosts numerous high-tech enterprises and research institutions. The park has attracted leading companies in integrated circuits, bio-pharmaceuticals, and software services, contributing significantly to the region's technological advancement.

Zhangjiang Group's portfolio includes investments in companies such as Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., a leading Chinese biopharmaceutical company specializing in innovative drugs, and IM Motors, an electric vehicle joint venture between SAIC Motor, Alibaba Group, and Zhangjiang Hi-Tech. These investments reflect the firm's commitment to advancing high-tech industries and promoting sustainable development in China.